MALVERN, Pa., Oct. 28, 2016 -- Aclaris Therapeutics, Inc., (NASDAQ:ACRS), a dermatologist-led, specialty pharmaceutical company focused on the development of medical and aesthetic dermatology treatments, has been named one of the Best Places to Work in PA for 2016 by the Best Companies Group. The awards program, created in 2000, is one of the first statewide programs of its kind in the country. The program is a public/private partnership between Team Pennsylvania Foundation, the Pennsylvania Department of Community and Economic Development, the Pennsylvania State Council of the Society for Human Resource Management, and the Central Penn Business Journal.
“It is a great honor to be named one of the Best Places to Work in Pennsylvania, and I’m pleased to share this award with all of my colleagues who help make Aclaris an exceptional company,” said Dr. Neal Walker, President and Chief Executive Officer of Aclaris. “We have built an extraordinary team of people who are committed to developing and commercializing new medical and aesthetic dermatology treatment options for patients with visible skin and hair conditions.”
This survey and awards program was designed to identify, recognize and honor the best places of employment in Pennsylvania, who are benefiting the state's economy and its workforce. Employers are categorized based upon the total number of employees they have in the United States, 25 to 249 employees and 250 or more employees.
To be considered for participation, companies had to fulfill the following eligibility requirements:
- Be a for-profit or not-for-profit business
- Be a publicly or privately held business
- Have a facility in Pennsylvania
- Have at least 25 employees working in Pennsylvania
- Be in business a minimum of one year.
Companies from across the state entered the two-part process to determine the 100 Best Places to Work in PA. The first part of this process was evaluating each nominated company's workplace policies, practices, philosophies, systems and demographics. This part of the process was worth approximately 25% of the total evaluation. The second part consisted of an employee survey to measure the employee experience. This part of the process was worth approximately 75% of the total evaluation. The combined scores determined the top companies and the final ranking. Best Companies Group managed the overall registration and survey process.
Aclaris will be recognized at the Best Places to Work in PA awards banquet on Thursday, December 1, 2016, at the Lancaster County Convention Center in Lancaster, PA. Rankings will be revealed at the ceremony. Tickets may be purchased online at www.CPBJ.com/events.
In addition to the public/private partnership, the program is supported by the following organizations: Lead Sponsor—Team Pennsylvania Foundation; Presenting Sponsors—BDO, USA and Conrad Siegel Actuaries; Major Sponsors—Harrisburg University, PA Department of Labor and Industry, Office of Vocational Rehabilitation and Saul Ewing LLP; Selfie Sponsor—CenturyLink; Founding Partners—Team Pennsylvania Foundation and the Central Penn Business Journal; Program Partners—The Department of Community and Economic Development and PA SHRM.
For more information on the Best Places to Work in PA, visit www.bestplacestoworkinpa.com or contact Emily Winslow, event coordinator at the Central Penn Business Journal at 717-236-4300 or [email protected].
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology. Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting Aclaris’ website at www.aclaristx.com.
Contact: Aclaris Contact Michael Tung, M.D. Vice President / Investor Relations 484-329-2140 [email protected] Media Contact Mariann Caprino TogoRun 917-242-1087 [email protected]


Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
OpenAI Addresses Security Vulnerability in macOS App Certification Process
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home 



